Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 35
Filter
1.
J Neurosci Res ; 100(8): 1573-1584, 2022 08.
Article in English | MEDLINE | ID: mdl-33751631

ABSTRACT

Prior work in male rodents established that the medial habenula-interpeduncular nucleus (MHb-IPN) pathway modulates nicotine withdrawal. Specifically, withdrawal severity has been closely associated with inhibitory tone in the IPN via interneurons that release γ-aminobutyric acid (GABA). Inhibitory tone in the IPN is regulated by projections from the MHb that co-release glutamate and acetylcholine. Within the IPN, inhibitory tone is also regulated via corticotropin-releasing factor type 1 (CRF1) receptors that control GABA release from local interneurons. This study extends previous work by comparing sex differences in GABA, glutamate, as well serotonin levels in the IPN during precipitated nicotine withdrawal. Sex differences in withdrawal-induced neurochemical effects were also compared following systemic administration of a CRF1 receptor antagonist. The results revealed that there were no group differences in serotonin levels in the IPN. A major finding was that females displayed a larger withdrawal-induced increases in GABA levels in the IPN than males. Also, withdrawal increased IPN glutamate levels in a similar manner in females and males. Blockade of CRF1 receptors produced a larger suppression of the withdrawal-induced increases in GABA levels in the IPN of females versus males, an effect that was likely related to the robust increase in glutamate following administration of the CRF1 receptor antagonist in females. These data suggest that amino acid systems in the IPN modulate sex differences in the behavioral effects of nicotine withdrawal. Furthermore, our data imply that medications that target stress-induced activation of the IPN may reduce withdrawal severity, particularly in females.


Subject(s)
Interpeduncular Nucleus , Substance Withdrawal Syndrome , Amino Acids/metabolism , Female , Glutamic Acid/metabolism , Humans , Interpeduncular Nucleus/metabolism , Male , Nicotine/pharmacology , Receptors, Corticotropin-Releasing Hormone , Serotonin/metabolism , gamma-Aminobutyric Acid/metabolism
2.
J Neurosci Res ; 100(2): 653-669, 2022 02.
Article in English | MEDLINE | ID: mdl-34882833

ABSTRACT

The role of increased brain inflammation in the development of neurodegenerative diseases is unclear. Here, we have compared cytokine changes in normal aging, motor neurone disease (MND), and Alzheimer's disease (AD). After an initial analysis, six candidate cytokines, interleukin (IL)- 4, 5, 6, 10, macrophage inhibitory protein (MIP)-1α, and fibroblast growth factor (FGF)-2, showing greatest changes were assayed in postmortem frozen human superior frontal gyri (n = 12) of AD patients, aging and young adult controls along with the precentral gyrus (n = 12) of MND patients. Healthy aging was associated with decreased anti-inflammatory IL-10 and FGF-2 levels. AD prefrontal cortex was associated with increased levels of IL-4, IL-5, and FGF-2, with the largest increase seen for FGF-2. Notwithstanding differences in the specific frontal lobe gyrus sampled, MND patients' primary motor cortex (precentral gyrus) was associated with increased levels of IL-5, IL-6, IL-10, and FGF-2 compared to the aging prefrontal cortex (superior frontal gyrus). Immunocytochemistry showed that FGF-2 is expressed in neurons, astrocytes, and microglia in normal aging prefrontal cortex, AD prefrontal cortex, and MND motor cortex. We report that healthy aging and age-related neurodegenerative diseases have different cortical inflammatory signatures that are characterized by increased levels of anti-inflammatory cytokines and call into question the view that increased inflammation underlies the development of age-related neurodegenerative diseases.


Subject(s)
Aging , Alzheimer Disease , Cytokines , Motor Neuron Disease , Aging/metabolism , Alzheimer Disease/metabolism , Astrocytes/metabolism , Cytokines/metabolism , Humans , Inflammation/metabolism , Microglia/metabolism , Motor Neuron Disease/metabolism , Young Adult
3.
J Neurosci Res ; 99(7): 1885-1901, 2021 07.
Article in English | MEDLINE | ID: mdl-33848365

ABSTRACT

Dopamine signaling in nucleus accumbens (NAc) is modulated by γ-aminobutyric acid (GABA), acting through GABA-A and GABA-B receptors: dysregulation of GABAergic control of dopamine function may be important in behavioral deficits in schizophrenia. We investigated the effect of GABA-A (muscimol) and GABA-B (baclofen) receptor agonists on electrically stimulated dopamine release. Furthermore, we explored whether drug-induced changes were disrupted by pretreatment with phencyclidine, which provides a well-validated model of schizophrenia. Using brain slices from female rats, fast-scan cyclic voltammetry was used to measure electrically stimulated dopamine release in NAc shell. Both muscimol and baclofen caused concentration-dependent attenuation of evoked dopamine release: neither effect was changed by dihydro-ß-erythroidine, a nicotinic acetylcholine receptor antagonist, or the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-type glutamate receptor antagonist, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), precluding indirect mechanisms using these transmitter systems in the GABAergic actions. In slices taken from rats pretreated with phencyclidine, the attenuation of evoked dopamine release by baclofen was abolished, but the attenuation by muscimol was unaffected. Since phencyclidine pretreatment was followed by drug-free washout period of at least a week, the drug was not present during recording. Therefore, disruption of GABA-B modulation of dopamine is due to long-term functional changes resulting from the treatment, rather than transient changes due to the drug's presence at test. This enduring dysregulation of GABA-B modulation of accumbal dopamine release provides a plausible mechanism through which GABA dysfunction influences accumbal dopamine leading to behavioral changes seen in schizophrenia and may provide a route for novel therapeutic strategies to treat the condition.


Subject(s)
Dopamine/metabolism , Nucleus Accumbens/drug effects , Nucleus Accumbens/metabolism , Schizophrenia/metabolism , gamma-Aminobutyric Acid/metabolism , Animals , Excitatory Amino Acid Antagonists/pharmacology , Female , GABA Agonists/pharmacology , Phencyclidine/pharmacology , Rats , Rats, Wistar
4.
J Neurosci Res ; 99(2): 502-517, 2021 02.
Article in English | MEDLINE | ID: mdl-33070365

ABSTRACT

Prior research investigating associations between hypertension, obesity, and apolipoprotein (APOE) genotype status with memory performance among older adults has yielded inconsistent results. This may reflect, in part, a lack of first accounting for the effects these variables have on structural brain changes, that in turn contribute to age-related memory impairment. The current study sought to clarify the relationships between these factors via path modeling. We hypothesized that higher body mass index (BMI), hypertension, and being an APOE-ε4 allele carrier would predict poorer memory scores, with much of these effects accounted for by indirect effects operating via differences in the integrity of temporal stem white matter. Participants included 125 healthy older adults who underwent neuropsychological assessment and diffusion-weighted MRI scanning. Direct effects were found for hypertension and demographic variables including age, sex, and education. Importantly, indirect effects were found for BMI, hypertension, APOE-ε4 status, age, and sex, where these factors predicted memory scores via their impact on temporal stem diffusion measures. There was also a dual effect of sex, with a direct effect indicating that females had better memory performance overall, and an indirect effect indicating that females with greater temporal stem diffusion had poorer memory performance. Results suggest that changes to the integrity of temporal white matter in aging may underpin reduced memory performance. These results highlight that accounting for variables that not only directly impact cognition, but also for those that indirectly impact cognition via structural brain changes, is crucial for understanding the impact of risk factors on cognition.


Subject(s)
Aging/psychology , Apolipoprotein E4/genetics , Heart Disease Risk Factors , Memory Disorders/physiopathology , Memory/physiology , Temporal Lobe/physiopathology , Aged , Aged, 80 and over , Body Mass Index , Comorbidity , Diffusion , Diffusion Magnetic Resonance Imaging , Educational Status , Female , Humans , Hypertension/epidemiology , Likelihood Functions , Male , Memory Disorders/diagnostic imaging , Memory Disorders/epidemiology , Middle Aged , Models, Neurological , Neuroimaging , Neuropsychological Tests , Sex Factors , Statistics, Nonparametric , Temporal Lobe/diagnostic imaging , White Matter/diagnostic imaging , White Matter/physiopathology
5.
J Neurosci Res ; 99(6): 1689-1703, 2021 Jun.
Article in English | MEDLINE | ID: mdl-33713502

ABSTRACT

The lateral hypothalamus (LH) plays a key role in the maintenance of cortical activation and wakefulness. In the LH, the two main neuronal cell populations consist of excitatory glutamatergic neurons and inhibitory GABAergic neurons. Recent studies have shown that inhibitory LH GABAergic neurons are wake-promoting. However, the mechanism by which excitatory LH glutamatergic neurons contribute to sleep-wake regulation remains unclear. Using fiber photometry in male mice, we demonstrated that LH glutamatergic neurons exhibited high activities during both wakefulness and rapid eye movement sleep. Chemogenetic activation of LH glutamatergic neurons induced an increase in wakefulness that lasted for 6 hr, whereas suppression of LH glutamatergic neuronal activity caused a reduction in wakefulness. Brief optogenetic activation of LH glutamatergic neurons induced an immediate transition from slow-wave sleep to wakefulness, and long-lasting optogenetic stimulation of these neurons maintained wakefulness. Moreover, we found that LH-locus coeruleus/parabrachial nucleus and LH-basal forebrain projections mediated the wake-promoting effects of LH glutamatergic neurons. Taken together, our data indicate that LH glutamatergic neurons are essential for the induction and maintenance of wakefulness. The results presented here may advance our understanding of the role of LH in the control of wakefulness.


Subject(s)
Glutamates/physiology , Hypothalamic Area, Lateral/physiology , Neurons/physiology , Wakefulness/physiology , Animals , Excitatory Amino Acid Agonists/pharmacology , GABAergic Neurons , Male , Mice , Optogenetics , Polysomnography , Sleep Stages , Sleep, REM/physiology
6.
J Neurosci Res ; 99(6): 1704-1721, 2021 Jun.
Article in English | MEDLINE | ID: mdl-33729626

ABSTRACT

The importance of mitogen-activated protein kinase (MAPK) pathway signaling in regulating microglia-mediated neuroinflammation in Alzheimer's disease (AD) remains unclear. We examined the role of MAPK signaling in microglia using a preclinical model of AD pathology and quantitative proteomics studies of postmortem human brains. In multiplex immunoassay analyses of MAPK phosphoproteins in acutely isolated microglia and brain tissue from 5xFAD mice, we found phosphorylated extracellular signal-regulated kinase (ERK) was the most strongly upregulated phosphoprotein within the MAPK pathway in acutely isolated microglia, but not whole-brain tissue from 5xFAD mice. The importance of ERK signaling in primary microglia cultures was next investigated using transcriptomic profiling and functional assays of amyloid-ß and neuronal phagocytosis, which confirmed that ERK is a critical regulator of IFNγ-mediated pro-inflammatory activation of microglia, although it was also partly important for constitutive microglial functions. Phospho-ERK was an upstream regulator of disease-associated microglial gene expression (Trem2, Tyrobp), as well as several human AD risk genes (Bin1, Cd33, Trem2, Cnn2), indicative of the importance of microglial ERK signaling in AD pathology. Quantitative proteomic analyses of postmortem human brain showed that ERK1 and ERK2 were the only MAPK proteins with increased protein expression and positive associations with neuropathological grade. In a human brain phosphoproteomic study, we found evidence for increased flux through the ERK signaling pathway in AD. Overall, our analyses strongly suggest that ERK phosphorylation, particularly in microglia in mouse models, is a regulator of pro-inflammatory immune responses in AD pathogenesis.


Subject(s)
Alzheimer Disease/genetics , Alzheimer Disease/immunology , MAP Kinase Signaling System/genetics , Microglia/immunology , Amyloid beta-Peptides/metabolism , Animals , Female , Gene Expression , Male , Mice , Phagocytosis , Phosphorylation , Primary Cell Culture , Transcriptome
7.
J Neurosci Res ; 99(2): 699-728, 2021 02.
Article in English | MEDLINE | ID: mdl-33181864

ABSTRACT

Neuronal diversity in the cochlea is largely determined by ion channels. Among voltage-gated channels, hyperpolarization-activated cyclic nucleotide-gated (HCN) channels open with hyperpolarization and depolarize the cell until the resting membrane potential. The functions for hearing are not well elucidated and knowledge about localization is controversial. We created a detailed map of subcellular location and co-expression of all four HCN subunits across different mammalian species including CBA/J, C57Bl/6N, Ly5.1 mice, guinea pigs, cats, and human subjects. We correlated age-related hearing deterioration in CBA/J and C57Bl/6N with expression levels of HCN1, -2, and -4 in individual auditory neurons from the same cohort. Spatiotemporal expression during murine postnatal development exposed HCN2 and HCN4 involvement in a critical phase of hair cell innervation. The huge diversity of subunit composition, but lack of relevant heteromeric pairing along the perisomatic membrane and axon initial segments, highlighted an active role for auditory neurons. Neuron clusters were found to be the hot spots of HCN1, -2, and -4 immunostaining. HCN channels were also located in afferent and efferent fibers of the sensory epithelium. Age-related changes on HCN subtype expression were not uniform among mice and could not be directly correlated with audiometric data. The oldest mice groups revealed HCN channel up- or downregulation, depending on the mouse strain. The unexpected involvement of HCN channels in outer hair cell function where HCN3 overlaps prestin location emphasized the importance for auditory function. A better understanding may open up new possibilities to tune neuronal responses evoked through electrical stimulation by cochlear implants.


Subject(s)
Aging/metabolism , Cochlea/metabolism , Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels/physiology , Neurons/metabolism , Potassium Channels/physiology , Animals , Cats , Cochlea/growth & development , Evoked Potentials, Auditory, Brain Stem , Female , Gene Expression Regulation , Guinea Pigs , Hearing Loss, Sensorineural/genetics , Hearing Loss, Sensorineural/metabolism , Humans , Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels/biosynthesis , Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels/genetics , Male , Mice , Mice, Inbred C57BL , Mice, Inbred CBA , Neurons/ultrastructure , Potassium Channels/biosynthesis , Potassium Channels/genetics , Subcellular Fractions/metabolism
8.
J Neurosci Res ; 98(10): 2027-2044, 2020 10.
Article in English | MEDLINE | ID: mdl-32741029

ABSTRACT

Millions suffer a traumatic brain injury (TBI) each year wherein the outcomes associated with injury can vary greatly between individuals. This study postulates that variations in each biomechanical parameter of a head trauma lead to differences in histological and behavioral outcome measures that should be considered collectively in assessing injury. While trauma severity typically scales with the magnitude of injury, much less is known about the effects of rate and duration of the mechanical insult. In this study, a newly developed voice-coil fluid percussion injury system was used to investigate the effects of injury rate and fluid percussion impulse on a collection of post-injury outcomes in male rats. Collectively the data suggest a potential shift in the specificity and progression of neuronal injury and function rather than a general scaling of injury severity. While a faster, shorter fluid percussion first presents as a mild TBI, neuronal loss and some behavioral tasks were similar among the slower and faster fluid percussion injuries. This study concludes that the sequelae of neuronal degeneration and behavioral outcomes are related to the complete temporal profile of the fluid percussion and do not scale only with peak pressure.


Subject(s)
Biomechanical Phenomena/physiology , Brain Injuries, Traumatic/pathology , Brain Injuries, Traumatic/physiopathology , Maze Learning/physiology , Animals , Brain Injuries, Traumatic/psychology , Cell Survival/physiology , Male , Rats , Rats, Sprague-Dawley , Time Factors
9.
J Neurosci Res ; 98(4): 718-733, 2020 04.
Article in English | MEDLINE | ID: mdl-31797419

ABSTRACT

In Krabbe disease, a mutation in GALC gene causes widespread demyelination determining cell death by apoptosis, mainly in oligodendrocytes and Schwann cells. Less is known on the molecular mechanisms induced by this deficiency. Here, we report an impairment in protein synthesis and degradation and in proteasomal clearance with a potential accumulation of the misfolded proteins and induction of the endoplasmic reticulum stress in the brain of 6-day-old twitcher mice (TM) (model of Krabbe disease). In particular, an imbalance of the immunoproteasome function was highlighted, useful for shaping adaptive immune response by neurological cells. Moreover, our data show an involvement of cytoskeleton remodeling in Krabbe pathogenesis, with a lamin meshwork disaggregation in twitcher oligodendrocytes in 6-day-old TM. This study provides interesting protein targets and mechanistic insight on the early onset of Krabbe disease that may be promising options to be tested in combination with currently available therapies to rescue Krabbe phenotype.


Subject(s)
Leukodystrophy, Globoid Cell/metabolism , Lysosomal Storage Diseases/metabolism , Oligodendroglia/metabolism , Proteostasis , Animals , Disease Models, Animal , Female , Lamins/metabolism , Male , Mice, Inbred C57BL , Mice, Transgenic , Oligodendroglia/ultrastructure , Proteomics
10.
J Neurosci Res ; 97(9): 1051-1065, 2019 09.
Article in English | MEDLINE | ID: mdl-31081159

ABSTRACT

Repeated opioids abuse may produce long-lasting and complicated cognitive deficits in individuals. Naloxone is a typical mu-opioid receptor antagonist widely used in clinical treatment for opioid overdose and opioid abuse. However, it remains unclear whether naloxone affects morphine-induced cognitive deficits. Using the 5-choice serial reaction time task (5-CSRTT), the present study investigated cognitive profiles including attention, impulsivity, compulsivity, and processing speed in repeated morphine-treated mice. Repeated morphine administration (10 mg/kg, i.p.) induced complex cognitive changes including decreased attention and increased impulsivity, compulsivity, processing speed. Systemic naloxone administration (5 mg/kg, i.p.) reversed these cognitive changes under the heavy perceptual load in 5-CSRTT. Using the novel object recognition (NOR), Y-maze and open-field test (OFT), the present study investigated the memory ability and locomotor activity. Naloxone reversed the effect of morphine on recognition memory and locomotion but had no effect on working memory. In addition, repeated morphine administration decreased the expression of postsynaptic density protein 95 (PSD95) and cAMP response element binding protein (CREB) phosphorylation in the prefrontal cortex (PFC) and hippocampus (HIP), and these effects were significantly reversed by naloxone in PFC. Our study suggests that repeated exposure to morphine affects multiple cognitive aspects and impairs synaptic functions. Systemic naloxone treatment reverses the mu-opioids-induced cognitive changes, especially under the heavy perceptual load, possibly by restoring the synaptic dysfunctions.


Subject(s)
Analgesics, Opioid/adverse effects , Cognitive Dysfunction/drug therapy , Morphine/adverse effects , Naloxone/pharmacology , Narcotic Antagonists/pharmacology , Animals , Cognition/drug effects , Cyclic AMP Response Element-Binding Protein/metabolism , Disks Large Homolog 4 Protein/metabolism , Hippocampus/drug effects , Hippocampus/metabolism , Learning/drug effects , Male , Maze Learning/drug effects , Mice , Mice, Inbred C57BL , Prefrontal Cortex/drug effects , Prefrontal Cortex/metabolism , Reaction Time/drug effects , Receptors, Opioid, mu , Recognition, Psychology/drug effects , Signal Transduction
11.
J Neurosci Res ; 97(4): 492-505, 2019 04.
Article in English | MEDLINE | ID: mdl-30461032

ABSTRACT

Oxidative stress refers to an imbalance between oxidative and antioxidative systems due to environmental factors. Although oxidative stress is implicated in the pathogenesis of Alzheimer's disease (AD), its precise role is not yet understood. We aimed to investigate the pathogenic mechanisms of the oxidative stress by using in vitro cultured neurons and in vivo AD models of PS1V97L-transgenic (Tg) mice. Our results showed that when oxidative stress became increasingly evident, the endogenous protective pathway of nuclear factor E2-related factor 2 (Nrf2)/antioxidant response element (ARE) decreased in 10-month-old PS1V97L-Tg mice. Activating the Nrf2/ARE pathway suppressed oxidative stress, decreased amyloid-ß (Aß), and improved the cognitive function of the PS1V97L-Tg mice. In contrast, blocking the Nrf2/ARE pathway augmented oxidative injury and decreased the cell viability of PS1V97L-Tg neurons. Our results highlight the role of the Nrf2/ARE pathway in regulating oxidative stress of the PS1V97L-Tg mice and may indicate a potential therapeutic avenue for AD treatment.


Subject(s)
Alzheimer Disease/metabolism , Antioxidant Response Elements , NF-E2-Related Factor 2/metabolism , Oxidative Stress/physiology , Amyloid beta-Peptides/metabolism , Animals , Brain/metabolism , Cell Survival/genetics , Cognition , Cognitive Dysfunction , Heme Oxygenase-1/metabolism , Maze Learning , Membrane Proteins/metabolism , Mice , Mice, Inbred C57BL , Mice, Transgenic , NAD(P)H Dehydrogenase (Quinone)/metabolism , NF-E2-Related Factor 2/deficiency , Neurons/metabolism , beta-Transducin Repeat-Containing Proteins
12.
J Neurosci Res ; 97(2): 215-224, 2019 02.
Article in English | MEDLINE | ID: mdl-30311670

ABSTRACT

People showing symptoms of attention deficit hyperactivity disorder (ADHD) often present an impairment of reaction time and response inhibition. These executive functions are influenced by nicotinergic acetylcholine receptors (nAchr) as mediators of cholinergic signaling, and show differences between both sexes. We examined the effects of two functional polymorphisms rs3841324 (S/L) and rs16969968 (G/A) of the cholinergic gene CHRNA5, ADHD symptoms and sex on response inhibition/reaction time in the Stop Signal Task. In the analyses, 183 participants (52.4% females) were included. In participants carrying the diplotype (SS_GG), men with ADHD symptoms responded faster, while men without ADHD symptoms were slower than women (F = 5.313; p = 0.023; ηp ² = 0.034). Although explorative, this threefold interaction on reaction time but not response inhibition extend previous findings, suggesting a moderating effect of ADHD symptoms in men carrying the CHRNA5 diplotype SS_GG and might inspire research on genotype- and gender-specific ADHD medication.


Subject(s)
Attention Deficit Disorder with Hyperactivity/genetics , Executive Function , Reaction Time , Receptors, Nicotinic/genetics , Sex Factors , Adolescent , Adult , Aged , Child , Female , Genotype , Humans , Male , Middle Aged , Polymorphism, Single Nucleotide
13.
J Neurosci Res ; 97(10): 1266-1277, 2019 10.
Article in English | MEDLINE | ID: mdl-31257630

ABSTRACT

Anoxia during delivery is a complication that can disturb infant brain development leading to various types of neurological disorders. Our studies have shown that increased body temperature of newborn rats of both sexes intensifies the postanoxic oxidative stress and prevents triggering the endogenous adaptive response such as HIF-1α activation. Currently, brain-derived neurotrophic factor-BDNF is considered to be a modulator of neuronal plasticity. In the developing brain, mature BDNF and its precursor exhibit prosurvival action through the TrkB receptor and proapoptotic functions binding to p75NTR , respectively. The aim of our experiments was to check the effects of body temperature on the postanoxic level of BDNF and on the expression of its receptors as well as on the marker of apoptosis-caspase-3 in the rat brain. Two-day-old Wistar Han rats (male/female ratio, 1:1) were exposed to anoxia in 100% nitrogen atmosphere for 10 min in different thermal conditions, which allowed them to regulate their rectal temperature at the following levels: normothermic-33°C; hyperthermic-37°C; and extremely hyperthermic-39°C. Thermal conditions during neonatal anoxia affected the level of proBDNF, BDNF as well as their receptors and caspase-3 in the forebrain. The increased BDNF protein level followed by decreased caspase-3 protein level was probably dependent on body temperature under anoxic conditions and was observed only in rats maintaining decreased body temperature. The positive effect of BDNF was not observed under hyperthermic conditions. Moreover, BDNF level changes correlated with body temperature probably affected the learning and spatial memory in juvenile rats.


Subject(s)
Body Temperature/physiology , Brain-Derived Neurotrophic Factor/metabolism , Brain/metabolism , Hypoxia, Brain/metabolism , Animals , Animals, Newborn , Asphyxia Neonatorum/metabolism , Caspase 3/metabolism , Female , Male , Rats , Rats, Wistar , Receptor, trkB/metabolism
14.
J Neurosci Res ; 97(9): 1095-1109, 2019 09.
Article in English | MEDLINE | ID: mdl-31119788

ABSTRACT

Parkinson's disease (PD) is a disabling and highly costly neurodegenerative condition with worldwide prevalence. Despite advances in treatments that slow progression and minimize locomotor impairments, its clinical management is still a challenge. Previous preclinical studies, using mesenchymal stem cell (MSC) transplantation and isolated physical exercise (EX), reported beneficial results for treatment of PD. Therefore, this experimental randomized study aimed to elucidate the therapeutic potential of combined therapy using adipose-derived human MSCs (ADSCs) grafted into the striatum in conjunction with aerobic treadmill training, specifically in terms of locomotor performance in a unilateral PD rat model induced by 6-hydroxydopamine (6-OHDA). Forty-one male Wistar rats were categorized into five groups in accordance with the type of treatment to which they were subjected (Sham, 6-OHDA - injury, 6-OHDA + exercise, 6-OHDA + cells, and 6-OHDA + combined). Subsequently, dopaminergic depletion was assessed by the methylphenidate challenge and the specified therapeutic intervention was conducted in each group. The foot fault task was performed at the end of the experiment to serve as an assessment of motor skills. The results showed that despite disturbances in motor balance and coordination, locomotor dysfunction was ameliorated in all treatment categories in comparison to the injury group (sign test, p < 0.001, effect size: 0.71). The exercise alone and combined groups were the categories that exhibited the best recovery in terms of movement performance (p < 0.001). Overall, this study confirms that exercise is a powerful option to improve motor function and a promising adjuvant intervention for stem cell transplantation in the treatment of PD motor symptoms. OPEN PRACTICES: This article has been awarded Open Data. All materials and data are publicly accessible at https://figshare.com/s/18a543c101a17a1d5560. Learn more about the Open Practices badges from the Center for Open Science: https://osf.io/tvyxz/wiki.


Subject(s)
Mesenchymal Stem Cell Transplantation , Parkinson Disease, Secondary/therapy , Physical Conditioning, Animal , Animals , Dopaminergic Neurons/metabolism , Humans , Male , Mesenchymal Stem Cells/cytology , Mesenchymal Stem Cells/metabolism , Methylphenidate , Motor Activity/drug effects , Oxidopamine , Parkinson Disease, Secondary/chemically induced , Rats , Rats, Wistar , Substantia Nigra/metabolism , Tyrosine 3-Monooxygenase/metabolism , Ventral Tegmental Area/metabolism
15.
J Neurosci Res ; 96(1): 103-116, 2018 01.
Article in English | MEDLINE | ID: mdl-28752903

ABSTRACT

Stress-induced allostatic load affects a variety of biological processes including synaptic plasticity, angiogenesis, oxidative stress, and inflammation in the brain, especially in the hippocampus. Erythropoietin (EPO) is a pleiotropic cytokine that has shown promising neuroprotective effects. Recombinant human EPO is currently highlighted as a new candidate treatment for cognitive impairment in neuropsychiatric disorders. Because EPO enhances synaptic plasticity, attenuates oxidative stress, and inhibits generation of proinflammatory cytokines, EPO may be able to modulate the effects of stress-induced allostatic load at the molecular level. The aim of this study was therefore to investigate how EPO and repeated restraint stress, separately and combined, influence (i) behavior in the novelty-suppressed feeding test of depression/anxiety-related behavior; (ii) mRNA levels of genes encoding proteins involved in synaptic plasticity, angiogenesis, oxidative stress, and inflammation; and (iii) remodeling of the dendritic structure of the CA3c area of the hippocampus in male rats. As expected, chronic restraint stress lowered the number of CA3c apical dendritic terminals, and EPO treatment reversed this effect. Interestingly, these effects seemed to be mechanistically distinct, as stress and EPO had differential effects on gene expression. While chronic restraint stress lowered the expression of spinophilin, tumor necrosis factor α, and heat shock protein 72, EPO increased expression of hypoxia-inducible factor-2α and lowered the expression of vascular endothelial growth factor in hippocampus. These findings indicate that the effects of treatment with EPO follow different molecular pathways and do not directly counteract the effects of stress in the hippocampus.


Subject(s)
CA3 Region, Hippocampal/metabolism , Dendrites/metabolism , Erythropoietin/therapeutic use , Neovascularization, Pathologic/metabolism , Oxidative Stress/physiology , Stress, Psychological/metabolism , Animals , CA3 Region, Hippocampal/drug effects , CA3 Region, Hippocampal/pathology , Chronic Disease , Dendrites/drug effects , Dendrites/pathology , Erythropoietin/pharmacology , Gene Expression , Inflammation/drug therapy , Inflammation/metabolism , Inflammation/pathology , Male , Neovascularization, Pathologic/drug therapy , Neovascularization, Pathologic/pathology , Neuronal Plasticity/drug effects , Neuronal Plasticity/physiology , Oxidative Stress/drug effects , Presynaptic Terminals/drug effects , Presynaptic Terminals/metabolism , Presynaptic Terminals/pathology , Rats , Rats, Sprague-Dawley , Restraint, Physical , Stress, Psychological/drug therapy , Stress, Psychological/pathology
16.
J Neurosci Res ; 96(1): 87-102, 2018 01.
Article in English | MEDLINE | ID: mdl-28639376

ABSTRACT

Ischemic stroke is a devastating neurological disorder and one of the leading causes of death and serious disability in adults. Adult neural stem cell (NSC) replacement therapy is a promising treatment for both structural and functional neurological recovery. However, for the treatment to work, adult NSCs must be protected against hypoxic-ischemic damage in the ischemic penumbra. In the present study, we aimed to investigate the neuroprotective effects of the mfat-1 transgene on cobalt chloride (CoCl2 )-induced hypoxic-ischemic injury in cultured adult NSCs as well as its underlying mechanisms. The results show that in the CoCl2 -induced hypoxic-ischemic injury model, the mfat-1 transgene enhanced the viability of adult NSCs and suppressed CoCl2 -mediated apoptosis of adult NSCs. Additionally, the mfat-1 transgene promoted the proliferation of NSCs as shown by increased bromodeoxyuridine labeling of adult NSCs. This process was related to the reduction of reactive oxygen species. Quantitative real-time polymerase chain reaction and Western blot analysis revealed a much higher expression of nuclear factor erythroid 2-related factor 2 (Nrf2) and its downstream genes (HO-1, NQO-1, GCLC). Taken together, our findings show that the mfat-1 transgene restored the CoCl2 -inhibited viability and proliferation of NSCs by activating nuclear factor erythroid 2-related factor 2 (Nrf2)/antioxidant response elements (ARE) signal pathway to inhibit oxidative stress injury. Further investigation of the function of the mfat-1 transgene in adult protective mechanisms may accelerate the development of adult NSC replacement therapy for ischemic stroke.


Subject(s)
Caenorhabditis elegans Proteins/biosynthesis , Carboxylic Ester Hydrolases/metabolism , Cobalt/toxicity , Fatty Acid Desaturases/biosynthesis , NF-E2-Related Factor 2/metabolism , Neural Stem Cells/metabolism , Age Factors , Animals , Caenorhabditis elegans Proteins/genetics , Cell Hypoxia/physiology , Cells, Cultured , Fatty Acid Desaturases/genetics , Mice , Mice, Inbred C57BL , Mice, Transgenic , Neural Stem Cells/drug effects , Neural Stem Cells/pathology , Signal Transduction/drug effects , Signal Transduction/physiology , Transgenes/physiology
17.
J Neurosci Res ; 95(10): 1894-1905, 2017 10.
Article in English | MEDLINE | ID: mdl-28266723

ABSTRACT

Epilepsy is one of the most common neurologic disorders worldwide with no distinguishable cause in 60% of patients. One-third of world's population is infected with Toxoplasma gondii (T. gondii). This intracellular parasite has high tendency to excitable cells including neurons. We assessed seizure susceptibility and involvement of dopaminergic system in male mice with acute and chronic T. gondii infection. Mice were infected by intraperitoneal injection of T. gondii cysts. Acute and chronic stages of infection were determined by quantification of SAG1/BAG1 transcripts and level of repetitive REP-529 sequence in the brain of mice by real-time PCR. Threshold of clonic seizures was measured by tail vein infusion of pentylenetetrazole. The infected mice were pretreated with D1 and D2 dopamine receptor antagonists, and seizure threshold was measured. Moreover, seizure threshold was determined after treatment of toxoplasmosis by sulfamethoxazole and trimethoprim. SAG1 level reached the maximum at week 2 after infection and then declined. The maximum level of BAG1 was observed at the week 3 and preserved till the week 8. REP-529 was detected at first week after infection, reached maximum at the week 3 and kept at this level till the eighth week. Threshold of seizures significantly decreased in both acute and chronic phases of infection. D1 and D2 receptors antagonists inhibited proconvulsant effect of toxoplasmosis. Chemotherapy inhibited parasite growth and multiplication, and returned seizure susceptibility to the level of non-infected mice. Dopaminergic neurotransmission participates in proconvulsant effect of T. gondii. The effect of parasite is eliminated by antibiotic therapy. © 2017 Wiley Periodicals, Inc.


Subject(s)
Dopamine/metabolism , Seizures/metabolism , Seizures/microbiology , Synaptic Transmission/physiology , Toxoplasmosis/complications , Animals , Dopamine Antagonists/pharmacology , Male , Mice , Synaptic Transmission/drug effects , Trimethoprim, Sulfamethoxazole Drug Combination/pharmacology
18.
J Neurosci Res ; 95(7): 1446-1458, 2017 07.
Article in English | MEDLINE | ID: mdl-27781303

ABSTRACT

Neurogenesis is a well-characterized phenomenon within the dentate gyrus (DG) of the adult hippocampus. Aging and chronic degenerative disorders have been shown to impair hippocampal neurogenesis, but the consequence of chronic inflammation remains controversial. In this study the chronic experimental autoimmune encephalomyelitis (EAE) mouse model of multiple sclerosis was used to investigate the long-term effects of T cell-mediated central nervous system inflammation on hippocampal neurogenesis. 5-Bromodeoxyuridine (BrdU)-labeled subpopulations of hippocampal cells in EAE and control mice (coexpressing GFAP, doublecortin, NeuN, calretinin, and S100) were quantified at the recovery phase, 21 days after BrdU administration, to estimate alterations on the rate and differentiation pattern of the neurogenesis process. The core features of EAE mice DG are (i) elevated number of newborn (BrdU+) cells indicating vigorous proliferation, which in the long term subsided; (ii) enhanced migration of newborn cells into the granule cell layer; (iii) increased level of immature neuronal markers (including calretinin and doublecortin); (iv) trending decrease in the percentage of newborn mature neurons; and (v) augmented gliogenesis and differentiation of newborn neural precursor cells (NPCs) to mature astrocytes (BrdU+/S100+). Although the inflammatory environment in the brain of EAE mice enhances the proliferation of hippocampal NPCs, in the long term neurogenesis is progressively depleted, giving prominence to gliogenesis. The discrepancy between the high number of immature cells and the low number of mature newborn cells could be the result of a caused defect in the maturation pathway. © 2016 Wiley Periodicals, Inc.


Subject(s)
Encephalomyelitis, Autoimmune, Experimental/immunology , Encephalomyelitis, Autoimmune, Experimental/pathology , Hippocampus/pathology , Hippocampus/physiology , Neural Stem Cells/physiology , Neurogenesis/physiology , Age Factors , Animals , Cell Movement/physiology , Cell Proliferation/physiology , Female , Inflammation/immunology , Inflammation/pathology , Mice , Mice, Inbred C57BL , Time Factors
19.
J Neurosci Res ; 94(10): 907-14, 2016 10.
Article in English | MEDLINE | ID: mdl-27312674

ABSTRACT

Previous research has examined the effects of exercise in experimental autoimmune encephalomyelitis (EAE), the animal model of multiple sclerosis. However, all previous studies have utilized a chronic model of EAE, with exercise delivered prior to or immediately after induction of EAE. To our knowledge, no study has examined the effects of exercise delivered during a remission period after initial disease onset in a relapsing-remitting model of EAE (RR-EAE). The current study examines the effects of both voluntary wheel running and forced treadmill exercise on clinical disability and hippocampal brain-derived neurotrophic factor (BDNF) in SJL mice with RR-EAE. The results demonstrate no significant effects of exercise delivered during remission after initial disease onset on clinical disability scores or levels of hippocampal BDNF in mice with RR-EAE. Furthermore, our results demonstrate no significant increase in citrate synthase activity in the gastrocnemius and soleus muscles of mice in the running wheel or treadmill conditions compared with the sedentary condition. These results suggest that the exercise stimuli might have been insufficient to elicit differences in clinical disability or hippocampal BDNF among treatment conditions. © 2016 Wiley Periodicals, Inc.


Subject(s)
Disease Models, Animal , Encephalomyelitis, Autoimmune, Experimental/physiopathology , Physical Conditioning, Animal/physiology , Animals , Brain-Derived Neurotrophic Factor/metabolism , Citrate (si)-Synthase/metabolism , Encephalomyelitis, Autoimmune, Experimental/chemically induced , Encephalomyelitis, Autoimmune, Experimental/pathology , Exercise Test , Female , Freund's Adjuvant/toxicity , Hippocampus/metabolism , Mice , Motor Activity/physiology , Multiple Sclerosis/chemically induced , Multiple Sclerosis/pathology , Multiple Sclerosis/physiopathology , Muscles/pathology , Myelin Proteolipid Protein/immunology , Myelin Proteolipid Protein/toxicity , Organ Size , Peptide Fragments/immunology , Peptide Fragments/toxicity , Random Allocation , Recurrence , Running/physiology , Spinal Cord/metabolism , Spinal Cord/pathology
SELECTION OF CITATIONS
SEARCH DETAIL